Literature DB >> 17117293

Office practice of osteoporosis evaluation.

Paulo Gustavo S Lacativa1, Maria Lucia F de Farias.   

Abstract

Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. Bone fragility depends on bone density, turnover and microarchitectural features, such as relative trabecular volume, spacing, number and connectivity. Previous fragility fractures increase the fracture risk irrespective of bone density. Other risk factors must also be considered as many fractures occur in patients with osteopenia on densitometry. On the other hand, the diagnosis of osteoporosis and increased fracture risk should not be based on densitometric data alone when young populations such as men below 65 years, premenopausal women, adolescents and children are considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117293     DOI: 10.1590/s0004-27302006000400013

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  4 in total

1.  Bone mineral density and nutritional profile in morbidly obese women.

Authors:  Daniela Schaan Casagrande; Giuseppe Repetto; Claudio Corá Mottin; Rodolfo Schneider; Jacqueline Rizzolli; Myriam Moretto; Alexandre Vontobel Padoin; Beatriz D'Agord Schaan
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

2.  Angelica polysaccharide promotes proliferation and osteoblast differentiation of mesenchymal stem cells by regulation of long non-coding RNA H19: An animal study.

Authors:  Xiaoyan Xie; Miao Liu; Qiang Meng
Journal:  Bone Joint Res       Date:  2019-08-02       Impact factor: 5.853

3.  Bone mineral density and muscle mass in adults with developmental skeletal discrepancies.

Authors:  Reza Sharifi; Sheida Kordi; Farhad Noravesh; Yasaman Aghababaei; Majid Ramezani; Zhila Maghbooli
Journal:  BMC Musculoskelet Disord       Date:  2022-06-20       Impact factor: 2.562

4.  Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing's disease.

Authors:  Weihong Guo; Fengao Li; Chonggui Zhu; Baoping Wang; Kunling Wang; Chenlin Dai; Hongwei Jia; Hongyan Wei; Qing He; Jin Cui; Menghua Yuan; Shaofang Tang; Wei Liu; Tiehong Zhu; Zhihong Gao; Fangqiu Zheng; Zhongshu Ma; Huiqi Qu; Mei Zhu
Journal:  J Int Med Res       Date:  2017-08-29       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.